Politics and practice guidelines: a volatile mix
The Health Policy Exchange
MARCH 14, 2013
It's understandable that this episode made future AHRQ leaders reluctant to wade into explosive scientific controversies, especially regarding sacred cows of medicine such as mammography and prostate cancer screening. Although the agency survived, this experience eventually drove it out of the guideline-producing business for good.
130 
Let's personalize your content